Clinical Trial Update: Study on Repeat Liposomal Bupivacaine for Post-Surgery Pain in Anal Fistula Patients. [NA]

View source ↗

Summary

A clinical trial is evaluating repeat administration of liposomal bupivacaine for postoperative pain in anal fistula patients and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Fistula

Drugs mentioned

• Liposomal Bupivacaine (Exparel) (bupivacaine liposome injectable suspension)

Snippet

Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University | Conditions: Anal Fistula | NA | Status: RECRUITING